FOLD

Amicus Therapeutics Stock Price

15.55
-0.01 (-0.06%)
Upgrade to Real-Time
Afterhours (Closed)
15.56
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Amicus Therapeutics Inc FOLD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.01 0.06% 15.56 15.49 15.86 15.80 15.55 00:00:01
Bid Price Ask Price Spread Spread % News
14.35 16.88 2.53 14.99% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
14,127 1,496,670 $ 15.69 $ 23,488,321 3,393,607 6.25 - 15.91
Last Trade Time Type Quantity Stock Price Currency
16:42:07 3 $ 15.55 USD

Amicus Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.01B 257.66M 256.09M $ 182.24M $ - -1.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Amicus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FOLD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week14.8715.9114.7115.442,810,8320.694.64%
1 Month12.8315.9110.4813.613,531,7682.7321.28%
3 Months10.2515.919.75512.642,815,6355.3151.8%
6 Months9.8215.916.2510.812,981,3115.7458.45%
1 Year12.4515.916.2510.332,884,3253.1124.98%
3 Years10.1117.626.2512.302,762,0625.4553.91%
5 Years14.0418.834.4110.662,677,3371.5210.83%

Amicus Therapeutics Description

Amicus Therapeutics is a biotechnology company that operates through one business segment focused on the discovery, development, and commercialization of medicines for various rare metabolic diseases. The firm offers Galafold, an orally administered small-molecule drug to treat Fabry disease. The company is also conducting clinical studies for an investigational enzyme replacement therapy for Pompe disease. Amicus Therapeutics has strategic manufacturing collaborations with Thermo Fisher Scientific and Catalent Biologics for multiple clinical programs.


Your Recent History
NASDAQ
FOLD
Amicus The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.